Top

Journal of Endocrinological Investigation

Published in:

01-05-2014 | Editorial

Hypovitaminosis D in primary hyperparathyroidism: to treat or not to treat? That is the question

Authors: Salvatore Minisola, Elisabetta Romagnoli, Alfredo Scillitani, Sudhakar D. Rao

Published in: Journal of Endocrinological Investigation | Issue 5/2014

Abstract

This is an Editorial in relation to the article of Rathi M et al. (J Endocrinol Invest, doi:10.1007/s40618-014-0056-y), emphasizing the issue of hypovitaminosis D in patients with primary hyperparathyroidism.

Romagnoli E, Pepe J, Piemonte S, Cipriani C, Minisola S (2013) Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation. Eur J Endocrinol 169:R59–R69PubMedCrossRef

Carnevale V, Manfredi G, Romagnoli E, De Geronimo S, Paglia F, Pepe J, Scillitani A, D’Erasmo E, Minisola S (2004) Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage? Clin Endocrinol (Oxf). 60:81–86PubMedCrossRef

Bollerslev J, Marcocci C, Sosa M, Nordenström J, Bouillon R, Mosekilde L (2011) Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol 165:851–864PubMedCrossRef

Shah VN, Shah CS, Bhadada SK, Rao DS (2014) Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature. Clin Endocrinol (Oxf). doi:10.1111/cen.12398. [Epub ahead of print]

Silverberg SJ, Shane E, Dempster DW, Bilezikian JP (1999) The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 107:561–567PubMedCrossRef

Rao DS (1999) Perspective on assessment of vitamin D nutrition. J Clin Densitom 2:457–464PubMedCrossRef

Zierold C, Mings JA, DeLuca HF (2003) Regulation of 25-hydroxyvitamin D3-24-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone. J Cell Biochem 88:234–237PubMedCrossRef

Clements MR, Davies M, Fraser DR, Lumb GA, Mawer EB, Adams PH (1987) Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci (Lond). 73:659–664PubMed

Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L (2005) Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) 63:506–513CrossRef

10.

Rao DS, Honasoge M, Divine GW, Phillips ER, Lee MW, Ansari MR, Talpos GB, Parfitt AM (2000) Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 85:1054–1058PubMed

11.

Stein EM, Dempster DW, Udesky J, Zhou H, Bilezikian JP, Shane E, Silverberg SJ (2011) Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism. Bone 48:557–561PubMedCentralPubMedCrossRef

12.

Rolighed L, Rejnmark L, Sikjaer T, Heickendorff L, Vestergaard P, Mosekilde L, Christiansen P (2014) Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab jc20133978. [Epub ahead of print]

13.

Rathi M, Gonzalez S, Ellis N, Wright D, Peacey S (2014) Management of hypovitaminosis D in patients with primary hyperparathyroidism. J Endocrinol Invest. doi:10.1007/s40618-014-0056-y

14.

Isidro ML, Ruano B (2009) Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency. Endocrine 36:305–310PubMedCrossRef

15.

Tucci JR (2009) Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D. Eur J Endocrinol 161:189–193PubMedCrossRef

16.

Grey A, Lucas J, Horne A, Gamble G, Davidson JS, Reid IR (2005) Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab 90:2122–2126PubMedCrossRef

17.

Minisola S, Romagnoli E, Scarnecchia L, Rosso R, Pacitti MT, Scarda A, Mazzuoli G (1994) Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism: studies in basal conditions and after parathyroid surgery. Eur J Endocrinol 130:587–591PubMedCrossRef

18.

Minisola S, Scarnecchia L, Scarda A, Bigi F, Tabolli S, Valtorta C, Mazzuoli G (1988) Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery. Miner Electrolyte Metab 14:201–207PubMed

Title: Hypovitaminosis D in primary hyperparathyroidism: to treat or not to treat? That is the question
Authors: Salvatore Minisola
Elisabetta Romagnoli
Alfredo Scillitani
Sudhakar D. Rao
Publication date: 01-05-2014
Publisher: Springer International Publishing
Published in: Journal of Endocrinological Investigation / Issue 5/2014
Electronic ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-014-0060-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2014

Effect of maternal nicotine/thiocyanate exposure during gestational period upon pituitary, thyroid and parathyroid function/morphology of 1-month-old rat offspring

The role of hip and chest radiographs in osteoporotic evaluation among south Indian women population: a comparative scenario with DXA

Achieving HbA1c targets in clinical trials and in the real world: a systematic review and meta-analysis

The “slower” the better

Winthrop Chandler “Concealing Enlarged Thyroid” (6 April 1747 – 9 July 1790)

Pantoprazole may improve beta cell function and diabetes mellitus

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials